Specifications
Species Reactivity
Rat; Human
Immunogen
Recombinant fragment within Human CSGALNACT2 aa 150-250. The exact sequence is proprietary.Database link: Q8N6G5
Applications
Application Notes
WB: 1/1000 - 1/10000.
Target
Alternative Names
CSGALNACT2; chondroitin sulfate N-acetylgalactosaminyltransferase 2; chondroitin beta1; 4 N acetylgalactosaminyltransferase 2; GALNACT 2; GALNACT2; MGC40204; PRO0082; beta4GalNAcT-2; beta 4 GalNAcT-2; chondroitin sulfate GalNAcT-2; chondroitin beta1,4 N-a
Product Background
Antigen Description
Transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). Required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains.
Pathway
Glycosaminoglycan biosynthesis - chondroitin sulfate, organism-specific biosystem; Glycosaminoglycan biosynthesis - chondroitin sulfate, conserved biosystem; Glycosaminoglycan biosynthesis, chondroitin sulfate backbone, organism-specific biosystem; Glycosaminoglycan biosynthesis, chondroitin sulfate backbone, conserved biosystem; Metabolic pathways, organism-specific biosystem; chondroitin and dermatan biosynthesis, organism-specific biosystem; chondroitin and dermatan biosynthesis, conserved biosystem.
Citations
Publication ()
Have you cited DCABH-7228 in a publication?
Let us know and earn a reward for your research.
COA
Loading ......
